antiarrhythmic

(redirected from Antiarrhythmic agent)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Wikipedia.

antiarrhythmic

[‚an·tē‚ā′rith·mik]
(medicine)
An agent that prevents or alleviates cardiac arrhythmia.
References in periodicals archive ?
Among those on the antiarrhythmic agent, 10% developed a rash, as did 7% of those on placebo.
These patients need warfarin therapy but not antiarrhythmic agents or electrical cardioversion unless there is hemodynamic compromise.
It offers clinicians a unique, ready-to-use antiarrhythmic agent for critical and time sensitive situations, while also providing convenience to caregivers and value to pharmacists," said Robert M.
Hohnloser stressed that 'potential' needs to be emphasized because this was a posthoc analysis--distinguishes dronedarone from the various antiarrhythmic agents currently marketed for maintenance of sinus rhythm, all of which have been shadowed by safety concerns.
Using Captisol enabled Prism Pharmaceuticals to formulate NEXTERONE Premixed Injection without the cosolvents polysorbate 80 and benzyl alcohol used in the innovator product - the antiarrhythmic agent amiodarone IV originally marketed as Cordarone([R] )Intravenous.
Recently, Prism received FDA approval for NEXTERONE(R) (amiodarone HCl) Injection, a novel, patent-protected, cosolvent free formulation of the antiarrhythmic agent Amiodarone IV.
SOFA did not completely shut the door on fish oil as an antiarrhythmic agent, however.
Food and Drug Administration (FDA) approval of Prism's new drug application (NDA) for NEXTERONE(R) (amiodarone HCl) Injection, a novel, patent-protected, cosolvent free formulation of the antiarrhythmic agent Amiodarone IV.
to develop a novel formulation of the antiarrhythmic agent Amiodarone IV (originally marketed as Cordarone([R]) Intravenous) without the cosolvents polysorbate 80 and benzyl alcohol that are used in the innovator product.
Cooper will present corporate strategy and highlight the recent FDA approval of the Company's new drug application (NDA) for NEXTERONE(R) (amiodarone HCl) Injection, a novel, patent-protected, cosolvent free formulation of the antiarrhythmic agent Amiodarone IV.
NEW ORLEANS -- The novel antiarrhythmic agent RSD1235 effectively converted atrial fibrillation to sinus rhythm in a median of just 11 minutes in its initial phase III clinical trial, Dennis Roy, M.